Filing Details
- Accession Number:
- 0001209191-18-058085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-13 09:14:51
- Reporting Period:
- 2018-11-09
- Accepted Time:
- 2018-11-13 09:14:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1419600 | Flexion Therapeutics Inc | FLXN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1296999 | David Arkowitz | C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-09 | 4,000 | $16.56 | 48,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for the transaction reported was $16.5554, and the range of prices were between $16.5461 and $16.5595. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Billionaire Hedge Funds
